Skip to main content

“Face Lifting” of the Newborn Chest-Surfactant and Extracorporeal Membrane Oxygenation

  • Conference paper
Highlights of Pediatric Radiology

Part of the book series: Syllabus ((SYLLABUS))

  • 81 Accesses

Abstract

Important recent advances have been made in the management of newborn infants with respiratory distress. Few therapeutic maneuvers have had a greater impact than surfactant and extracorporeal membrane oxygenation (ECMO). Surfactant is a relatively inexpensive drug, administered quite easily through an endotracheal tube, and has had its greatest impact on the premature infant population in whom ECMO is usually contraindicated. Conversely, ECMO is a highly advanced, expensive, time and staff intensive, technically demanding procedure used mostly in full-term babies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Long WA, Guangbin Z, Henry GW (1996) Pharmacologic adjuncts IL exogenous surfactants. In: Goldsmith JP, Karotkin EH (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia. pp 305–325

    Google Scholar 

  2. Avery ME, Mead J (1959) Surface active properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 17: 517–523

    Google Scholar 

  3. Chu J, Clements JA, Cotton EK. et al. (1967) Neonatal pul-monary ischemia. Part 1: clinical and physiological studies. Pediatrics 40: 709–782

    PubMed  Google Scholar 

  4. Robillard E, Alaire Y, Dagenais-Perusse P, et al. (1964) Microaerosol administration of synthectic beta-gamma-dipalmitoyl-L-alpha-lecithin in the respiratory distress syndrome: a preliminary report. Can Med Assoc J 90: 55–57

    PubMed  CAS  Google Scholar 

  5. Hawgood S, Clements JA (1990) Surfactant and its apoproteins. J Clin Invest 86: 1

    Article  PubMed  CAS  Google Scholar 

  6. Soll RF (1997) Surfactant therapy in the USA: trials and current routines. Biol Neonate 71 (Suppl 1): 1–7

    PubMed  Google Scholar 

  7. Fujiwara T, Chida S, Watabe Y, et al. (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55–59

    Article  PubMed  CAS  Google Scholar 

  8. Hennes HM, Lee MB, Rimm AA, Shapiro DL (1991) Surfactant replacement therapy in respiratory distress syndrome. AJDC 145: 102–104

    PubMed  CAS  Google Scholar 

  9. Dunn MS, Shennan AT, Possmayer F (1990) Single-versus multiple-dose surfactant replacement therapy in neonates of 30–36 weeks’ gestation with respiratory distress syndrome. Pediatrics 86: 564–571

    PubMed  CAS  Google Scholar 

  10. Phibbs RH, Ballard RA, Clements JA, Heilbron DC, Phibbs CS. Schlueter MA, et al. (1991) Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of Hyaline membrane disease. Pediatrics 88: 1–9

    PubMed  CAS  Google Scholar 

  11. Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328: 861–868

    Article  PubMed  CAS  Google Scholar 

  12. McColley SA (1998) Bronchopulmonary dysplasia. Impact of surfactant replacement therapy. Pediatr Clin North Am 45: 573–585

    Article  PubMed  CAS  Google Scholar 

  13. Kattwinkel J (1998) Surfactant: evolving issues. Clin Perinatol 25: 17–32

    PubMed  CAS  Google Scholar 

  14. Soll RF (1996) Appropriate surfactant usage in 1996. Eur J Pediatr 155 (Suppl 2): 8–13

    Article  Google Scholar 

  15. Morley CJ (1997) Systematic review of prophylactic vs rescue surfactant. Arch Dis Child 77: F70–F74

    CAS  Google Scholar 

  16. Schimmel MS (1995) Respiratory distress syndrome: therapeutic aspects. Pediatr Radiol 25: 641–642

    Article  PubMed  CAS  Google Scholar 

  17. Dinger J, Schwarze R, Rupprecht E (1997) Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome. Pediatr Radiol 27: 26–31

    Article  PubMed  CAS  Google Scholar 

  18. Skinner JR (1997) The effects of surfactant on haemodynamics in hyaline membrane disease. Arch Dis Child Fetal Neonatal Ed 76: F67–F69

    Article  PubMed  CAS  Google Scholar 

  19. Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, et al. (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 132: 40–47

    Article  PubMed  CAS  Google Scholar 

  20. Cleveland RH (1995) A radiologic update on medical diseases of the newborn chest. Pediatr Radiol 25: 631–637

    Article  PubMed  CAS  Google Scholar 

  21. Dimitriou G, Greenough A, Griffin FJ, Karani J (1995) The appearance of “early” chest radiographs and the response to surfactant replacement therapy. Br J Radiol 68: 1177–1180

    Article  PubMed  CAS  Google Scholar 

  22. Swischuk LE, Shetty BP, John SD (1996) The lungs in immature infants: how important is surfactant therapy in preventing chronic lung problems? Pediatr Radiol 26: 508–511

    Article  PubMed  CAS  Google Scholar 

  23. Soll RF (1998) Surfactant treatment of the very preterm infant. Biol Neonate 74 (Suppl 1): 35–42

    Article  PubMed  CAS  Google Scholar 

  24. Clyman RI, Jobe A, Heymann M, Ikegami M, Roman C, Payne B, et al. (1982) Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 100: 101–107

    Article  PubMed  CAS  Google Scholar 

  25. Wood BP (1993) The newborn chest. Radiol Clin North Am 31: 667–676

    PubMed  CAS  Google Scholar 

  26. Hamvas A, Nogee LM, Mallory GB Jr., Spray TL, Huddleston CB, August A, et al. (1997) Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130: 231–239

    Article  PubMed  CAS  Google Scholar 

  27. Goetzman BW. Milstein JM (1996) Pharmacologic adjuncts I. In: Goldsmith JP. Karotkin EH (eds) Assisted ventilation of the neonate. WB Saunders, Philadelphia, pp 296–300

    Google Scholar 

  28. Northway WH (1992) Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 89: 969–973

    PubMed  Google Scholar 

  29. Kanto WP Jr, Bunyapen C (1998) Extracorporeal membrane oxygenation. Controversies in selection of patients and management. Clin Perinatol 25: 123–135

    PubMed  Google Scholar 

  30. Langer JC (1998) Congenital diaphragmatic hernia. Chest Surg Clin N Am 8: 295–314

    PubMed  CAS  Google Scholar 

  31. Stillerman LR, Gunn SB, Hart JC, Engle WA (1997) Effects of exogenous surfactant on neonates supported by extracorporeal membrane oxygenation. J Perinatol 17: 262–265

    PubMed  CAS  Google Scholar 

  32. Torosian MB, Statter MB, Arensman RM (1996) Extracor poreal membrane oxygenation. In: Goldsmith JP, Karotkin EH, (eds) Assisted ventilation of the neonate, 3rd edn. WB Saunders, Philadelphia, pp 241–256

    Google Scholar 

  33. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. (1976) Extracorporeal membrane oxygenation ( ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22: 80–93

    PubMed  CAS  Google Scholar 

  34. Fox WW, Dura S (1983) Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 103: 505–514

    Article  Google Scholar 

  35. Bartlett RH, Toomasian J, Roloff D, et al. (1986) Extracorporeal membrane oxygenation in neonatal respiratory failure: 100 cases. Ann Surg 204: 236–245

    Article  PubMed  CAS  Google Scholar 

  36. Short BL, Miller MK, Anderson KD (1987) Extracorporeal membrane oxygenation in the management of respiratory failure in the newborn. Clin Perinatol 14: 737–748

    PubMed  CAS  Google Scholar 

  37. Redmond CR, Graves ED, Falterman KW, et al. (1987) Extracorporeal membrane oxygenation for respiratory and cardiac failure in infants and children. J Thorac Cardiovasc Surg 93: 199–204

    PubMed  CAS  Google Scholar 

  38. Swischuk LE (1997) Imaging of the newborn, infant, and young child, 4th edn. Williams & Wilkins, Baltimore, pp 105–107

    Google Scholar 

  39. Knight GR, Dudell GG, Evans ML, Grimm PS (1996) A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. Crit Care Med 24: 1678–1683

    Article  PubMed  CAS  Google Scholar 

  40. Cornish JD, Heiss KF, Clark RH, et al. (1993) Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. J Pediatr 122: 105–109

    Article  PubMed  CAS  Google Scholar 

  41. DeAngelis GA, Mitchell DG, Merton DA, Wolfson PJ, Desai HJ, Desai SA, et al. (1992) Right common carotid artery reconstruction in neonates after extracorporeal membrane oxygenation: color Doppler imaging. Radiology 182: 521–525

    PubMed  CAS  Google Scholar 

  42. Gross GW, Cullen J, Kornhauser MS, Wolfson PJ (1992) Thoracic complications of extracorporeal membrane oxygenation: findings on chest radiographs and sonograms. AJR 158: 353–358

    PubMed  CAS  Google Scholar 

  43. Taylor GA, Short BL, Kriesmer P (1986) Extracorporeal membrane oxygenation: radiographic appearance of the neonatal chest. AJR 146: 1257–1260

    PubMed  CAS  Google Scholar 

  44. Kelly RE, Phillips JD, Foglia RP, et al. (1991) Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg 26: 1016–1022

    Article  PubMed  Google Scholar 

  45. Zwischenberger JB, Nguyen TT, Upp JR Jr, et al. (1994) Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 107: 838–848

    PubMed  CAS  Google Scholar 

  46. Weber TR, Kountzman B (1996) The effects of venous occlusion on cerebral blood flow characteristics during ECMO. J Pediatr Surg 31: 1124–1127

    Article  PubMed  CAS  Google Scholar 

  47. Kornhauser MS, Cullen JA, Baumgart S. et al. (1994) Risk factors for bronchopulmonary dysplasia after extracorporeal membrane oxygenation. Arch Pediatr Adolesc Med 148: 820–825

    Article  Google Scholar 

  48. Graziani LJ. Gringlas M, Baumgart S (1997) Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol 24: 655–675

    PubMed  CAS  Google Scholar 

  49. Bulas DI, Taylor GA, O’Donnell RM, Short BL, Fitz CR, Vezina G (1996) Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: update on sonographic and CT findings. AJNR 17: 287–294

    PubMed  CAS  Google Scholar 

  50. Hofkosh D, Thompson AE, Nozza RJ, et al. (1991) Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics 87: 549–555

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Newman, B. (1999). “Face Lifting” of the Newborn Chest-Surfactant and Extracorporeal Membrane Oxygenation. In: Bar-Ziv, J., Horev, G., Kalifa, G. (eds) Highlights of Pediatric Radiology. Syllabus. Springer, Milano. https://doi.org/10.1007/978-88-470-2253-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2253-9_1

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0061-2

  • Online ISBN: 978-88-470-2253-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics